Home
About
Overview
Sharing Data
ORCID
Help
History (55)
Neuropsychiatric symptoms in Brazilians with mild cognitive impairment and dementia.
Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells.
Application of a Beta-Tricalcium Phosphate Graft to Minimize Bony Defect in Bone-Patella Tendon-Bone Anterior Cruciate Ligament Reconstruction.
Pregnadienediols
What influences placebo and nocebo responses in Parkinson's disease?
See All 55 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
What influences placebo and nocebo responses in Parkinson's disease?
What influences placebo and nocebo responses in Parkinson's disease? Mov Disord. 2018 08; 33(8):1204-1212.
View in:
PubMed
subject areas
Catechol O-Methyltransferase
History, 18th Century
History, 19th Century
Humans
Nocebo Effect
Parkinson Disease
Placebo Effect
Polymorphism, Single Nucleotide
Treatment Outcome
authors with profiles
Christopher Goetz